Mirabegron, a Selective ß3-Adrenergic Receptor Agonist, as a Potential Anti-Obesity Drug.

Dabrowska, Anna Maria; Dudka, Jaroslaw

Dabrowska, Anna Maria; Dudka, Jaroslaw.

Affiliation

Dabrowska AM; Department of Toxicology, Medical University of Lublin, Jaczewskiego Street 8b, 20-090 Lublin, Poland.
Dudka J; Endocrinology Outpatient Clinic, Lublin, Poland.

J Clin Med ; 12(21)2023 Nov 02.

Article in En | MEDLINE | ID: mdl-37959362

Key words

brown adipose tissue; mirabegron; obesity; ß3-adrenergic receptor agonist; "beige" adipose tissue

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649615
https://dx.doi.org/10.3390/jcm12216897

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Med Year: 2023 Document type: Article Affiliation country: Poland

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649615
https://dx.doi.org/10.3390/jcm12216897

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Med Year: 2023 Document type: Article Affiliation country: Poland